This research looked at how doctors monitored patients with brain metastases who were treated with systemic therapy. The study reviewed medical records from a single hospital to see how often patients received MRI scans. It compared patients who followed specific medical guidelines for surveillance against those who did not.
Thirty-three patients were included in this analysis. The team tracked when patients had their first, second, and third MRI scans. They also looked at whether tumors grew locally or if patients needed brain radiation within one year. The results showed no clear difference in tumor growth or radiation use between the two groups.
Two patients experienced seizures while on the treatment. However, the study has important limitations that affect how we interpret the findings. It was a retrospective review of past records from one location, which limits what we can learn about the general population.
Because the study was small and observational, it cannot prove that following guidelines causes better results. These findings suggest more research is needed to create strong evidence for surveillance schedules. Patients should discuss monitoring plans with their care team based on individual needs and current medical advice.